Clinical Trials
3 trialsNCT05252585 2026-04-02
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
Novartis
Phase 4 Active not recruiting
NCT03525834 2021-09-09
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Novartis
Phase 4 Completed
NCT01217125 2012-03-08
Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis
Fundacio Puigvert
Phase 4 Completed